The widely prescribed beta-blocker atenolol is in short supply around the country. The FDA first reported an atenolol shortage on July 26. According to the FDA website, three companies that manufacture generic atenolol -- Mylan, Sandoz, and Teva -- say that the cause is a shortage of an active ingredient. A fourth manufacturer, Zydus, said that it "is able to supply its current customer demand and has increased capacity to support additional demand starting in August." , a website that provides information about drugs to consumers, said that the brand name version of atenolol, Tenormin, costs $400, compared with $4 for the generic versions. The site recommends to people who have trouble filling their prescription that "it might be a good idea to talk to your physician about switching to another beta blocker in the meantime." Possible alternatives are metoprolol tartrate, metoprolol succinate, and bisoprolol, according to the site. Cardiologists contacted for this article agreed with that advice. Scott Ratner, MD, a cardiologist in private practice in New York on Long Island, said "don't panic." He rarely uses atenolol these days. A healthcare improvement company developing a more stable and reliable supply chain for generic drugs in short supply, is collaborating with Baxter Healthcare Corporation to make additional generic drugs available for purchase through Premier’s group purchasing organization. Drug shortages have been on the rise for several years, with an estimated 210 drugs currently at risk or not readily available for U. hospitals, according to the national database maintained by the American Society of Health System Pharmacists (ASHP). With wide-ranging effects on patient care, drug shortages can add time and expense as providers search for therapeutic alternatives and manage supplies, potentially delaying certain elective surgeries. “Our agreement with Baxter is the latest milestone in Premier’s long-standing, multi-year role in working to eliminate drug shortages,” said Michael J. “Premier is committed to aggregating provider demand for products and creating a predictable sales channel for suppliers. This agreement allows Premier to work with Baxter on mitigating shortages that have plagued the market for years, marking the 92nd shortage product by the National Drug Code that we can now supply on a reliable basis.” Premier and Baxter are collaborating to supply metoprolol injection, a life-saving blood pressure medication often used to treat patients experiencing hypertensive emergencies, such as heart attacks. Baxter is adding metoprolol injection to its growing portfolio of generic medicines that are essential to hospital care. Metoprolol, which has been subject to shortages since 2016, will be available for purchase by any health system or healthcare provider at competitive price points. Amoxicillin and milk Celebrex side effects mayo clinic Is it illegal to buy viagra online in canada Maxalt 10 mg directions Shortage of Metoprolol Can Lead to Errors Metoprolol succinate extended-release tablets have been in short supply lately. This is a generic heart and blood pressure medicine used by many consumers. During a shortage of metoprolol succinate extended-release ER tablets about a decade ago, use of any beta-blockers after MI declined, but population-level patient outcomes did not seem to suffer, a new study shows. Current and Resolved Drug Shortages and Discontinuations Reported to FDA. Metoprolol Tartrate Injection, USP Lopressor Status Discontinuation »Therapeutic Categories Note If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players. European regulators decided to ban any sartan with any level of contamination with probable carcinogenic nitrosamines, but is allowing a 2-year grace period to change manufacturing processes before enforcement. () Sanofi and Regeneron said they would cut the list price for alirocumab (Praluent) to $5,850 per year, a 60% reduction, to match that for evolocumab (Repatha) after Amgen slashed that drug's price last October. ( Quick Takes) Most attendees at a paclixtaxel town hall session at the International Symposium on Endovascular Therapy also said they wouldn't change their practice regarding paclitaxel-coated balloons in that setting (69%). () A new generic drug supply chain company's first offering will be metoprolol injections for hypertensive emergencies, a drug which has been in short supply since 2016, parent company Premier announced. The American College of Chest Physicians updated its guidelines on pulmonary arterial hypertension. A novel wireless ventricular assist device uses coplanar energy transfer to give patients at least 6 hours of freedom from a holster and batteries has now been used in two patients. ( found more people now know all five common heart attack symptoms (39.6% in 2008 vs 50.2% in 2017) and to call 9-1-1 if someone is having a heart attack (91.8% in 2008 vs 94.9% in 2017). This is a generic heart and blood pressure medicine used by many consumers. The companies that make this medicine had stopped producing it because of problems with the quality of the tablets. Although the problem is beginning to resolve, the medicine may not be available when consumers try to fill or refill their prescriptions. One option is to purchase the brand version of this medicine, Toprol XL, which is still widely available. How-ever, consumers may have to pay more for this brand name medicine. If the brand name medicine is too expensive, another option is to switch to a generic tablets. Some of the less expensive generic medicine is becoming available again, but it is still in short supply. Metoprolol shortage Another hospital group targets drug shortages and says., Post-MI Beta-blocker Use Dropped During Metoprolol ER Shortage, but. Buy femara online indiaBuy viagra brightonViagra gifts Oct 15, 2018. During a shortage of metoprolol succinate extended-release ER tablets about a decade ago, use of any beta-blockers after MI declined, but. Post-MI Beta-blocker Use Dropped During Metoprolol ER Shortage.. FDA Drug Shortages - Food and Drug Administration. Don't panic There's a nationwide shortage of atenolol - Iodine. Jan 28, 2009. The Wall Street Journal Health Blog is reporting that a shortage of generic metoprolol succinate is causing trouble for some patients. Following. Oct 9, 2018. We evaluated the population-level impact of metoprolol extended release shortage that occurred in the United States in 2009 to 2010. American Regent is not currently marketing metoprolol injection.2 Athenex has metoprolol injection available.3 Baxter did not provide a reason for the shortage.4 Fresenius Kabi has metoprolol injection on shortage due to increased demand.5 Mylan Institutional acquired metoprolol injection from Sagent.